StockData

Alignment Healthcare vs Humana

ALHC and HUM side by side, both in accident and health insurance and medical. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How ALHC and HUM compare

Humana is the larger company, worth 33 times as much as Alignment Healthcare ($53.2B against $1.6B).

On earnings, Humana is cheaper: it trades at 41.8× trailing earnings, against 69.3× for Alignment Healthcare.

Alignment Healthcare grew revenue faster over the last twelve months (35.9% versus 18.3% for Humana).

Humana keeps more of each dollar of sales as profit, with a net margin of 0.88% compared with 0.59% at Alignment Healthcare.

Humana pays a dividend yielding 0.60%; Alignment Healthcare does not pay one.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricALHCHUM
Size and price
Market cap$1.6B$53.2B
Share price$7.62$443.34
Change, 1 year−53.9%87.0%
Change, 5 years−56.1%3.5%
Beta (5Y)0.631.10
Employees1,84967K
StockData Score
Total score99
Valuation score11
Growth score22
Performance score3 (better)1
Health score3 (better)1
Dividend score04 (better)
Valuation
P/E69.3×41.8× (better)
P/S0.3× (better)0.4×
P/B5.8×2.8× (better)
EV/EBITDA15.6×13.0× (better)
P/FCF20.7× (better)27.3×
FCF yield4.8% (better)3.7%
Fair value$4.97$297.30
Margin of safety−53.4%−49.1% (better)
Growth
Revenue growth (TTM)35.9% (better)18.3%
Revenue growth, 5Y average32.7% (better)10.9%
Net income growth (TTM)–−18.8%
EPS growth (TTM)–−18.8%
EPS growth, 5Y average–−17.2%
Profitability
Operating margin0.88%1.9% (better)
Net margin0.59%0.88% (better)
FCF margin1.6% (better)1.3%
Return on equity13.2% (better)6.8%
Return on invested capital–23.4%
Financial health
Debt / equity1.170.74 (better)
Net debt / EBITDA−5.57−2.86
Interest coverage2.6×3.8× (better)
Current ratio1.711.74 (better)
Altman Z-score4.274.66 (better)
Piotroski F-score55
Dividends and buybacks
Dividend yield–0.60%
Payout ratio–33.6%
Years of dividend growth–0
Dividend growth, 5Y average–7.8%
Buyback yield–0.28%
Shareholder yield0.00%0.88% (better)
Ownership
Held by institutions106%98.6%
Held by insiders4.6%0.32%
Insider net buying, 12 months−$517M−$2.4M (better)
Superinvestors holding–2
Short interest, % of float11.6%2.3%

Go deeper

Other comparisons

For information only, not investment advice. Check the source filings before relying on any figure.